Safety and Efficacy of Fingolimod and Natalizumab in Multiple Sclerosis After the Failure of First-Line Therapy: Single Center Experience Based on the Treatment of Forty-Four Patients

Related articles

04 Oct 2020 : Case report

Encapsulating Peritoneal Sclerosis: A Case Report and Literature Review

Ali I. Al-Lawati, Maha Al Shaibi, [...] Ghaitha Al Mahruqi, Titus Augustine, Zia Moinuddin, Meerah Al Hinai, Rana Al Moqbali, Hani Al Qadhi - Show fewer authors

DOI: 10.12659/AJCR.925341

24 Jan 2019 : Case report

Progressive Multifocal Leukoencephalopathy in the Absence of Typical Radiological Changes: Can We Make a Diagnosis?

Abdulrahman M. AlTahan, Thomas Berger, [...] Ibrahim A. AlOrainy, Husam AlTahan - Show fewer authors

DOI: 10.12659/AJCR.911521

31 Jan 2019 : Review article

Correlation Between Smoking and Passive Smoking with Multiple Sclerosis and the Underlying Molecular Mechanisms

Zhaowei Wang, Jianpin Xie, [...] Chenglong Wu, Guirong Xiao - Show fewer authors

DOI: 10.12659/MSM.912863

11 Jan 2018 : Case report

Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case

Jing Miao, Doreen E. Aboagye, [...] Boris Chulpayev, Lin Liu, Gary Ishkanian, Bangaruraju Kolanuvada, Dariush Alaie, Richard L. Petrillo - Show fewer authors

DOI: 10.12659/AJCR.906150

18 Aug 2018 : Clinical Research

Effect of Rehabilitation on Fatigue Level in Patients with Multiple Sclerosis

Wioletta Mikuľáková, Eleonóra Klímová, [...] Lucia Kendrová, Miloslav Gajdoš, Marek Chmelík - Show fewer authors

DOI: 10.12659/MSM.909183

11 Dec 2016 : Clinical Research

Could Heterozygous Beta Thalassemia Provide Protection Against Multiple Sclerosis?

Mehmet Ali Cikrikcioglu, Muhammed Emin Ozcan, [...] Gulistan Halac, Ilhami Gultepe, Kenan Celik, Yahya Sekin, Elif Ece Eser, Sebnem Burhan, Guven Cetin, Omer Uysal - Show fewer authors

DOI: 10.12659/MSM.898192

02 Sep 2017 : Clinical Research

The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy

Sabrina Giacoppo, Maria Ruscica, [...] Luigi Maria Grimaldi, Placido Bramanti, Emanuela Mazzon - Show fewer authors

DOI: 10.12659/MSM.903301

01 Sep 2015 : Animal Research

Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE)

Xichun Wang, Xiufeng Zheng, [...] Chong Ma, Libo Zhao - Show fewer authors

DOI: 10.12659/MSM.894564

13 Apr 2015 : Clinical Research

Decreased Endothelin-1 Plasma Levels in Multiple Sclerosis Patients: A Possible Factor of Vascular Dysregulation?

Irmina Jankowska- Lech, Barbara Terelak-Borys, [...] Iwona Grabska- Liberek, Witold Palasik, Wojciech Bik, Ewa Wolińska-Witort - Show fewer authors

DOI: 10.12659/MSM.890899

19 Sep 2014 : Original article

Evaluation of Hemodynamic Properties of Cerebral Venous Drainage in Patients with Multiple Sclerosis: A Case-Control Study

Ali Babaei Jandaghi, Dayan Amanian, [...] Seyed Ali Roudbari, Alireza Rajabzadeh Kanafi, Ramin Pourghorban - Show fewer authors

DOI: 10.12659/PJR.890690

01 Dec 2011

Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses

Petar Filipović Grčić, Meri Matijaca, [...] Ivo Lušić, Vesna Čapkun - Show fewer authors

DOI: 10.12659/MSM.882130

01 Apr 2011

Expression of Th-17 and RORgammat mRNA in Behçet’s Disease

Kamel Hamzaoui, Eya Bouali, [...] Imed Ghorbel, Monia Khanfir, Habib Houman, Agnes Hamzaoui - Show fewer authors

DOI: 10.12659/MSM.881720

01 Mar 2005 : Original article

Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue

Jussi Oskari Virtanen, John B. Zabriskie, [...] Vappu Sirén, Jacqueline E. Friedman, Michael J. Lyons, Mark Edgar, Antti Vaheri, Marjaleena Koskiniemi - Show fewer authors

01 Aug 2005

M2000: A Revolution in Pharmacology

Abbas Mirshafiey, Salvatore Cuzzocrea, [...] Bernd Rehm, Hidenori Matsuo - Show fewer authors